DRUG (Bright Minds Biosciences) Accounts Payable: $2.65 Mil (As of Mar. 2026)


DRUG Bright Minds Biosciences Inc DRUG
34 GF Score
Price $67.68
! 2 Warning Signs
View Full Analysis

What is Bright Minds Biosciences Accounts Payable?

Bright Minds Biosciences DRUG +1.59% 34 Accounts Payable is $2.65 Mil as of Mar. 2026. GuruFocus rates DRUG with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Bright Minds Biosciences's Accounts Payable for the quarter that ended in Mar. 2026 was $2.65 Mil.

Bright Minds Biosciences's quarterly Accounts Payable declined from Sep. 2025 ($1.24 Mil) to Dec. 2025 ($1.04 Mil) but then increased from Dec. 2025 ($1.04 Mil) to Mar. 2026 ($2.65 Mil).

Bright Minds Biosciences's annual Accounts Payable increased from Sep. 2023 ($0.14 Mil) to Sep. 2024 ($0.30 Mil) and increased from Sep. 2024 ($0.30 Mil) to Sep. 2025 ($1.24 Mil).

Bright Minds Biosciences Accounts Payable Related Terms

Bright Minds Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Bright Minds Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bright Minds Biosciences Accounts Payable Chart

Bright Minds Biosciences Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Accounts Payable
Get a 7-Day Free Trial 0.47 0.93 0.14 0.30 1.24

Bright Minds Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.37 1.24 1.04 2.65
DRUG
34GF Score
Bright Minds Biosciences Inc DRUG
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bright Minds Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.65 Mil mean?
Bright Minds Biosciences (DRUG) has a Accounts Payable of $2.65 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bright Minds Biosciences and its competitors.
Is Bright Minds Biosciences' Accounts Payable too high?
Bright Minds Biosciences' current Accounts Payable is $2.65 Mil. Overall, Bright Minds Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Bright Minds Biosciences' Accounts Payable compare to VRTX and REGN?
Bright Minds Biosciences' Accounts Payable of $2.65 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Bright Minds Biosciences and its competitors. Bright Minds Biosciences's current Accounts Payable is $2.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bright Minds Biosciences stock overvalued right now?
Bright Minds Biosciences (DRUG) has a current Accounts Payable of $2.65 Mil. The current Accounts Payable is $2.65 Mil. Bright Minds Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Bright Minds Biosciences (DRUG), the current Accounts Payable is $2.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bright Minds Biosciences Business Description

Other Exchanges DRUG:Canada
Address 19 Vestry Street, New York, NY, USA, 10013
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
34GF Score

Get the complete analysis for DRUG

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.68
Price